{"name":"JDP Therapeutics, Inc.","slug":"jdp-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"JDP-205 Injection","genericName":"JDP-205 Injection","slug":"jdp-205-injection","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Test Drug (JDP-205)","genericName":"Test Drug (JDP-205)","slug":"test-drug-jdp-205","indication":"Atrial fibrillation for stroke prevention","status":"phase_3"}]}],"pipeline":[{"name":"JDP-205 Injection","genericName":"JDP-205 Injection","slug":"jdp-205-injection","phase":"phase_3","mechanism":"JDP-205 Injection is a monoclonal antibody targeting the PD-1 receptor.","indications":["Non-small cell lung cancer, PD-L1 positive","Head and neck squamous cell carcinoma"],"catalyst":""},{"name":"Test Drug (JDP-205)","genericName":"Test Drug (JDP-205)","slug":"test-drug-jdp-205","phase":"phase_3","mechanism":"Test Drug (JDP-205) is a small molecule that targets a specific molecular pathway.","indications":["Atrial fibrillation for stroke prevention"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQMnk5QjUzdEFUVTZIckZ6UUEwRUF2TldRM203YXk0TTdEQzdTQjRiTnlvbVIwUnpDUHhZSUZkY1RKV3Fwak1yQVVBNzN4WXZhaGtJWG5IS1NKUXhTUEkxcDM1YkxjbGU1MTQtTTZ6X3QzcHBuSk8wOW1tQmFld2FJTTVRZFhpTXJaUjlDVF8xcnRpWHl6UFJENC0xcVVhVUdpQXpLVEloQS1OcWd2X2U3S3I3ZWRDQVlP?oc=5","date":"2020-08-03","type":"pipeline","source":"prnewswire.com","summary":"GTCR and TerSera Therapeutics Announce Acquisition of Xermelo - prnewswire.com","headline":"GTCR and TerSera Therapeutics Announce Acquisition of Xermelo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQWWR4Tzh2aFM5dUpoRzVfcUJTNFNVVmJtR3B2WDJRNHFqR3RCOExTWnNBc2tra09pVW1tbDk3MEp3bHhscWpKUEJ6bnBGUHYyM3hEOUJVY0tpS1ZhNEZUY2gxQWNYMkRMY0RxOXAxb093amkwUGNqaGZTR1pHSWY1SFd6Yno4UmFrbG1DaVJyWldORHBTN3BXa0NzMTRuN25LUVRDNmdZNHFWS0tGcFB0ZWFub0ZuRWJmSmc?oc=5","date":"2020-06-03","type":"pipeline","source":"The Stockton Record","summary":"Alumna donates $5M to Pacific’s pharmacy school - The Stockton Record","headline":"Alumna donates $5M to Pacific’s pharmacy school","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}